Article

Pioneer of ophthalmic plastic surgery followed his calling

Editor's Note: During the time I was a resident at Manhattan Eye, Ear and Throat Hospital (1969-1972), I had the good fortune to work with Byron Capleese Smith, MD. Those who knew him will never forget him, and those who were not able to know him will gain a small glimpse of his persona and his contributions, as written by Christopher Teng, MD. -Norman Medow, MD

Editor's Note: During the time I was a resident at Manhattan Eye, Ear and Throat Hospital (1969-1972), I had the good fortune to work with Byron Capleese Smith, MD. Those who knew him will never forget him, and those who were not able to know him will gain a small glimpse of his persona and his contributions, as written by Christopher Teng, MD.-Norman Medow, MD

"Positive consistent thinking aiming toward a goal in life, honesty, diligence, generosity, and persistent maturation towards maximum achievement at all time."-Byron Capleese Smith, MD1908-1990

When World War II began, Dr. Smith joined the armed forces. During the war, he served as chairman of the Department of Ophthalmology as well as plastic surgery for the First General American Army Hospital.

Many influences

World War II had a profound impact on medicine, and many of Dr. Smith's ideas were formulated and came into fruition during that time. After working with many foreign body removals from shattered aircraft windows, Dr. Smith realized that plastic glass (Plexiglas) was well-tolerated in both the cornea and anterior chamber.

During the winter of 1944 in Paris, Dr. Smith first met John Converse, MD, a well-regarded plastic surgeon. As a result of their many meetings, they realized that the combination of their skills in plastic surgery and ophthalmology would be mutually beneficial to advance patient care.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.